Latest Articles

Publication Date
Three-Dimensional Modeling of Deep Endometriosis from Pelvic MRI: Feasibility, Clinical Perception, and Preliminary Prospective Evaluation.

To evaluate the feasibility of three-dimensional (3D) modeling of deep endometriosis (DE) from pelvic MRI, to assess its perceived usefulness by gynecologic surgeons, and to explore its transposability in clinical …

Published: Feb. 19, 2026, midnight
The Paradox of Endometriosis in Mayer-Rokitansky-Kuster-Hauser Syndrome: Applying Three Criteria to Discriminate Between Retrograde Menstruation/Implantation and Coelomic Metaplasia/Embryonic Cell Rests Theories.

Background/Objectives: The scientific community is still divided between supporters of the implantation theory and researchers who advocate the theory of coelomic metaplasia/embryonic cell remnants to explain the initiation of endometriosis. …

Published: Feb. 19, 2026, midnight
Association between body mass index and anti-Müllerian hormone in women with ovarian endometrioma and dermoid cyst.

Adiposity influences reproductive function via endocrine and immune pathways. The association between body mass index (BMI) and anti-Müllerian hormone (AMH) in endometriosis is uncertain, and BMI may not fully capture …

Published: Feb. 19, 2026, midnight
Brenner tumor associated with mucinous cyst and endometriosis: a case report.

Brenner tumors are rare ovarian neoplasms that often coexist with other epithelial tumors, most commonly mucinous cystic neoplasms. The association of Brenner tumors with endometriosis is unusual and not well-documented …

Published: Feb. 19, 2026, midnight
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria

Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria

Published: Feb. 18, 2026, 11:46 p.m.
Get up to 42% off a Max annual subscription when you prepay for one year - Mashable

Get up to 42% off a Max annual subscription when you prepay for one year Mashable

Published: Feb. 18, 2026, 11 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com

Aprea reports second partial response in endometrial cancer trial Investing.com

Published: Feb. 18, 2026, 1:42 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal

Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally

Published: Feb. 18, 2026, noon
A 60-Year-Old Woman With Endometrial Intraepithelial Neoplasia: A Case of Persistent Postmenopausal Bleeding - Cureus

A 60-Year-Old Woman With Endometrial Intraepithelial Neoplasia: A Case of Persistent Postmenopausal Bleeding Cureus

Published: Feb. 18, 2026, 2:58 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!